SUNPHARMA's weekly performance was dismal, with a return of -4.11%, the lowest among its peers. The stock's volatility was relatively low at 8.61%, but its Sharpe Ratio of -1.92 indicates poor risk-adjusted returns. SUNPHARMA underperformed its peers, particularly DRREDDY and HINDUNILVR, and was considered a relatively low-risk stock this week.

[Volatility: 8.61%]